| Bioactivity | (d(CH2)51,Tyr(Me)2,Thr4,Orn8,des-Gly-NH29)-Vasotocin, an oxytocin receptor antagonist, abolishes oxytocin-enhanced inhibitory postsynaptic currents in CA1 pyramidal neurons[1]. |
| Name | (d(CH2)51,Tyr(Me)2,Thr4,Orn8,des-Gly-NH29)-Vasotocin |
| CAS | 115499-13-3 |
| Sequence | {β-Mercapto-β,β-cyclopentamethylene-propionyl}-{Tyr(Me)}-Ile-Thr-Asn-Cys-Pro-{Orn} (Disulfide bridge: Mpa1-Cys6) |
| Shortening | {β-Mercapto-β,β-cyclopentamethylene-propionyl}-{Tyr(Me)}-ITNCP-{Orn} (Disulfide bridge: Mpa1-Cys6) |
| Formula | C45H69N9O12S2 |
| Molar Mass | 992.21 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
(d(CH2)51,Tyr(Me)2,Thr4,Orn8,des-Gly-NH29)-Vasotocin
CAS: 115499-13-3 F: C45H69N9O12S2 W: 992.21
(d(CH2)51,Tyr(Me)2,Thr4,Orn8,des-Gly-NH29)-Vasotocin, an oxytocin receptor antagonist, abolishes oxytocin-enhanced inhib
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.